Pergolizzi, J.V., Jr., Mercadante, S., Echaburu, A.V., Van den Eynden, B., Fragoso, R.M., Mordarski, S., . . . Euromed Communications meeting. (2009). The role of transdermal buprenorphine in the treatment of cancer pain: An expert panel consensus. Current Medical Research and Opinion, 25(6), 1517–1528.doi: 10.1185/03007990902920731
To provide practical guidance regarding the use of transdermal buprenorphine to treat cancer pain, particularly in those who need high-dose treatment to achieve pain control
The report provides information regarding the pharmacology and safety profile of transdermal buprenorphine. In addition, authors present some information, from studies and case reports, regarding efficacy. Authors provide no comprehensive review of search result or appraisal method. They do not detail the panel’s process.
Expert opinion suggests that, for the treatment of cancer pain, transdermal buprenorphine is a useful alternative or adjunct to other medication.